$11.40
-0.31-2.65%
At close: -
$11.31
-0.09-0.79%
After Hours: Jan 31, 5:59 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Keros Therapeutics in recent months.
Browse guidance and forecast on all stocks.